MedTrace Logo

Resistance Training in Cardiovascular Disease Patients

NCT04638764 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 72

Last updated 2020-11-20

No results posted yet for this study

Summary

In this study coronary artery disease patients and patients with heart failure will be randomly assigned to three training groups: combined aerobic interval training with high intensity resistance training, combined aerobic interval training with low intensity resistance training and aerobic interval training.

Conditions

Interventions

OTHER

Aerobic interval training combined with high intensity resistance training

Patients enrolled in arm of the study will perform 12 weeks of combined aerobic interval training (5 intervals of cycling at the intensity of 50 %-80% of peak power obtained at baseline cardiopulmonary testing) combined with high intensity resistance training (3 sets of leg press at the intensity of 70 %- 80 % of one repetition maximum (1-RM)).

OTHER

Aerobic interval training combined with low intensity resistance training

Patients enrolled in arm of the study will perform 12 weeks of combined aerobic interval training (5 intervals of cycling at the intensity of 50 %-80% of peak power obtained at baseline cardiopulmonary testing) combined with high intensity resistance training (3 sets of leg press at the intensity of 30 %- 40 % 1-RM).

OTHER

Aerobic interval training

Patients enrolled in arm of the study will perform 12 weeks of aerobic interval training (5 intervals of cycling at the intensity of 50 %-80% of peak power obtained at baseline cardiopulmonary testing).

Sponsors & Collaborators

  • University of Ljubljana

    collaborator OTHER

  • University of Primorska

    collaborator OTHER

  • General Hospital Murska Sobota

    lead OTHER

Principal Investigators

  • Mitja Lainščak, MD, PhD · General Hospital Murska Sobota; University of Ljubljana, Faculty of Medicine

  • Tim Kambič, MKin · General Hospital Murska Sobota; University of Ljubljana, Faculty of Sport

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-11-23
Primary Completion
2021-06-30
Completion
2021-11-26

Countries

  • Slovenia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04638764 on ClinicalTrials.gov